腹腔镜联合人胎盘组织液治疗盆腔炎性疾病后遗症

来源 :人人健康 | 被引量 : 0次 | 上传用户:hustyhw
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的 :观察腹腔镜联合人胎盘组织液治疗盆腔炎性疾病后遗症的临床效果。方法 :本次研究将我院(阳江市阳东区人民医院)收治的54例盆腔炎性疾病所致不孕症患者随机分成联合组和对照组,予以对照组患者腹腔镜手术治疗,在对照组患者的基础上予以研究组患者盆腔内放置人胎盘组织液治疗。结果 :术后随访两组患者12~24个月,研究组患者妊娠时间为(5.9±0.8)个月,明显早于对照组患者的(8.6±1.3)个月(t=7.910;P<0.05),妊娠率为85.2%,明显高于对照组患者的59.3%(x2=4.523;P<0.05)。结论 :腹腔镜联合人胎盘组织液治疗盆腔炎性疾病后遗症,疗效确切、可靠,值得临床推广应用。 Objective: To observe the clinical effect of laparoscopic combined with placental tissue fluid in the treatment of pelvic inflammatory disease sequelae. Methods: 54 cases of infertility caused by pelvic inflammatory disease in our hospital (Yangdong Yangdong People’s Hospital) were randomly divided into the combined group and the control group. The patients in the control group were treated by laparoscopy. In the control group Patients were treated on the basis of placing the human placenta tissue fluid in the pelvis of the study group. Results: The patients in both groups were followed up for 12-24 months. The pregnancy time in the study group was (5.9 ± 0.8) months, significantly earlier than that in the control group (8.6 ± 1.3) months (t = 7.910; P <0.05 ), The pregnancy rate was 85.2%, which was significantly higher than that in the control group (59.3%, x2 = 4.523; P <0.05). Conclusion: Laparoscopic combined with human placental tissue fluid treatment of sequelae of pelvic inflammatory disease, the exact effect, reliable, worthy of clinical application.
其他文献